Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma, N. Engl. J. Med, vol.320, pp.197-204, 1989. ,
Treatment of highrisk acute leukemia with T cell-depleted stem cells from related donors with one fully mismatched HLA haplotype, N. Engl. J. Med, vol.339, pp.1186-1193, 1998. ,
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study, Lancet Oncol, vol.10, pp.489-500, 2009. ,
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants, Science, vol.295, pp.2097-2100, 2002. ,
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism, J. Exp. Med, vol.162, pp.1745-1759, 1985. ,
Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells, Br. J. Haematol, vol.93, pp.412-420, 1996. ,
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide, Biol. Blood Marrow Transplant, vol.14, pp.641-650, 2008. ,
T cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor, Bone Marrow Transplant, vol.49, pp.999-1008, 2014. ,
Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation, Biol. Blood Marrow Transplant, vol.16, pp.533-542, 2010. ,
Killer cell immunoglobulinlike receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide, Leukemia, vol.33, pp.230-239, 2019. ,
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications, Blood, vol.131, pp.247-262, 2018. ,
Validation and refinement of the disease risk index for allogeneic stem cell transplantation, Blood, vol.123, pp.3664-3671, 2014. ,
NK-cell alloreactivity is associated with acute Gvhd and decreased relapse incidence after T-replete haplo-identical allotransplant with high-dose post-transplant cyclophosphamide, Blood, vol.130, p.3262, 2017. ,
International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GvHD international consortium, Biol. Blood Marrow Transplant, vol.22, pp.4-10, 2016. ,
, , 2005.